From the latest episode of New Insight with Veeral Sheth, MD, guest Seemi Khan, MD, CMO of Alkeus Pharmaceuticals, provides updates on the TEASE clinical trial program evaluating gildeuretinol (ALK-001) for #stargardt Disease, a rare genetic #eyedisease.
7 сен 2024